HexClad, Still G.I.N. Unveil First-Ever Collaboration, Bringing Gordon Ramsay, Dr. Dre,  Snoop Dogg Together For A Next-Gen Cocktail Shaker

LOS ANGELES, Dec. 6, 2025 /PRNewswire/ — In a collaboration no one saw coming, but everyone will be happy it did, HexClad, the revolutionary cookware brand backed by Michelin-starred chef Gordon Ramsay, and Still G.I.N. By Dre and Snoop, the ultra-premium spirit from cultural icons Dr. Dre and Snoop Dogg, today unveiled their first joint product: the HexClad Cocktail Shaker.

This collaboration marks a first for both brands and the first time Ramsay, Dre, and Snoop have come together, mixing HexClad’s design-driven innovation with Still G.I.N.’s modern, premium approach to spirits.

The shaker captures what defines each brand: precision, quality, and a belief that everyday experiences deserve to feel elevated. It’s more than a shaker; it’s a refined expression of the craftsmanship both brands stand for.

Celebrated industrial designer Ini Archibong created the HexClad x Still G.I.N. Cocktail Shaker as the kind of piece that demands attention the moment it hits the bar, showcasing Still G.I.N.’s versatility across any cocktail, from classic recipes to modern creations. Drawing from the striking geometry of the Still G.I.N. bottle and HexClad’s iconic hexagon pattern, Ini created a shaker that’s modern, sculptural, and unapologetically smooth. The double-wall, vacuum-insulated stainless-steel body keeps cocktails ice-cold without watering them down. A hex-textured exterior gives it a luxe, unmistakable edge, while discreet unit measurement markers inside the cap ensure every pour hits exactly right.

“This collaboration bridges innovation, culture, and craftsmanship in a way that feels like a true expression of both brands. Gordon, Dre, and Snoop each set their own bar for excellence, and bringing their worlds together through this product is something we’re incredibly proud of,” said Danny Winer, HexClad CEO and Co-Founder.  “The shaker is engineered to perform, but it also carries the energy of the icons behind it.”

“What connects Still G.I.N. and HexClad is a commitment to design, innovation, and products that actually perform. We built our gin to be supremely mixable, whether you’re making classic gin cocktails or using it in something unexpected. This shaker captures that same versatility and attention to detail,” said Patrick Halbert, By Dre and Snoop CEO.

To announce the campaign, Gordon and Dre will star in a dynamic, humor-infused commercial spot created by KODE MEDIA and directed by Peter Franklyn Banks, that draws parallels between cooking and musical craft.  Available exclusively at HexClad.com in Gold and Chrome for $99, the shaker will elevate the cocktail ritual from start to finish, capturing the shared ethos of rebellion, innovation and excellence of both brands. Just in time for the holidays, the shaker is now available in the US, Canada, UK, Germany and Australia.

ABOUT HEXCLAD
HexClad is a global premium kitchenware brand based in Los Angeles, known for its patented hybrid technology that combines stainless steel with nonstick for unmatched performance, durability, and ease-of-use. Since its founding in 2016, HexClad has redefined modern cooking tools with a full line of high-performance products, including cookware, cutlery, cutting boards, aprons, and kitchen accessories. Sold through direct-to-consumer channels and strategic retail partners, HexClad has built a passionate global following by empowering cooks of all levels with products that break rules and challenge convention. The brand was named to the Inc. 5000 list of the fastest-growing private companies in America 2023-2025. Learn more at www.hexclad.com.

ABOUT BY DRE AND SNOOP
Dr. Dre and Snoop Dogg launched their namesake spirits brand in 2024 to instant success, with no signs of stopping. The iconic duo recently followed up its first release in this space – the innovative, award-winning canned cocktail line, Gin & Juice by Dre and Snoop – with another acclaimed effort: their first pure premium bottled spirit, Still G.I.N. by Dre and Snoop, which went on to take Masters Medal honors at the 2025 Gin Masters Awards. Paying homage to “Still D.R.E.” – the signature hit from Dre’s groundbreaking 2001 album featuring an immortal Snoop performance – Still G.I.N. by Dre and Snoop proves the ultimate clean, modern light gin, artisanally distilled in the U.S.A. to be defiantly smooth and supremely mixable.

Still G.I.N. by Dre and Snoop marks a natural evolution for the legendary pair. Long associated with gin throughout their reign as game-changing entertainer-entrepreneurs, to create their latest co-venture they took initial inspiration from Snoop Dogg’s timeless hit song “Gin and Juice” – which Dr. Dre produced for Snoop’s debut album Doggystyle. Distributed nationally by Southern Glazer’s Wine & Spirits, both Gin & Juice By Dre and Snoop and Still G.I.N by Dre and Snoop are available at major U.S. retailers and liquor stores. www.bydreandsnoop.com

Logo – https://laotiantimes.com/wp-content/uploads/2025/12/hexclad_logo.jpg

Logo – https://laotiantimes.com/wp-content/uploads/2025/12/still_g_i_n_logo_logo_logo_hexclad.jpg

Photo – https://mma.prnewswire.com/media/2839532/Cocktail_Shaker_HexClad.jpg

Video – https://mma.prnewswire.com/media/2839533/Hexclad_StillGIN_TheMix_16x9_32.mp4

In the news release, “Seegene Establishes French Subsidiary to Expand European Footprint”, issued 05-Dec-2025 by Seegene Inc. over PR Newswire, we are advised by the company that the first sub-headline should read “France becomes Seegene’s eighth overseas sales subsidiary and third in Europe, following Italy and Germany” rather than “France becomes Seegene’s ninth overseas sales subsidiary and third in Europe, following Italy and Germany“; The sixth paragraph should read “The addition of France brings Seegene’s overseas sales subsidiaries to eight, complementing its global distribution network of 90 distributors across 94 countries.” rather than “The addition of France brings Seegene’s overseas sales subsidiaries to nine, complementing its global distribution network of 90 distributors across 94 countries.” as originally issued inadvertently. Complete, corrected release follows:

Seegene Establishes French Subsidiary to Expand European Footprint

–  France becomes Seegene’s eighth overseas sales subsidiary and third in Europe, following Italy and Germany

– The country ranks as Europe’s second-largest molecular diagnostics market, driven by demand in sexually transmitted infections and gastrointestinal testing, and respiratory virus detection.

– The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

SEOUL, South Korea, Dec. 5, 2025 /PRNewswire/ — Seegene, Inc., a global leader in molecular diagnostics (MDx), announced today the establishment of a new subsidiary in France to reinforce its European presence and support global sales expansion.

The new subsidiary will strengthen local engagement with customers and partners through enhanced technical support, market development and collaboration with healthcare stakeholders.

According to global market research firm Grand View Research, Inc., France’s MDx market is estimated to reach approximately EUR 600 million, accounting for around 15 percent of Europe’s total. It is the second-largest market in the region after Germany, which holds a 19 percent share. Demand in France is particularly high for diagnostic tests targeting sexually transmitted infections (STIs), gastrointestinal (GI) tract infections, and respiratory infections. Through its subsidiary, Seegene aims to expand sales of these product lines while introducing a broader portfolio including cervical cancer and other multiplex diagnostic categories.

“On the French market, which is divided between the private and public sectors, the ability to quickly deliver innovative products and meet laboratories’ efficiency needs is a key factor for competitiveness,” said Daniel Shin, Executive Vice President and Chief Global Sales and Marketing Officer at Seegene. “The subsidiary will enable Seegene to gain a better understanding the French healthcare landscape, strengthening local customer service, and accelerate the growth of the company’s in vitro diagnostics business with dedicated local expertise.”

The subsidiary also provides a strategic foothold for the European rollout of Seegene’s solutions that are in development, CURECA™, a fully automated, unmanned PCR system, and STAgora™, a real-time diagnostic data analytics and predictive insights platform.

The addition of France brings Seegene’s overseas sales subsidiaries to eight, complementing its global distribution network of 90 distributors across 94 countries.

As of the first half of 2025, overseas sales accounted for approximately 93 percent of Seegene’s total revenue, with Europe representing 63 percent. The region remains a key growth driver for the company’s global expansion roadmap.

Disclaimer

CURECA™ and STAgora™ are under development and not available for diagnostic use.

About Seegene

Seegene has more than 25 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene’s syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information.

Visit: Seegene.com and follow linkedin.com/company/seegene-inc

A palm-sized device that watches your pan, learns your style, and guides you to consistent results—no screens, no voices, just beeps and light.

SAN FRANCISCO, Dec. 6, 2025 /PRNewswire/ — A New Era of Intuitive Cooking Begins

For many, the joy of cooking is often overshadowed by anxiety. A new recipe can feel like a high-stakes experiment: the fear of incorrect heat, mistimed steps, or overcooked ingredients is all too real. Even confident home cooks approach unfamiliar dishes with trepidation, while beginners can feel utterly overwhelmed.

This universal kitchen dilemma is now being solved. Cue Chef Innovation, a pioneering new brand at the intersection of culinary art and applied technology, today unveils Cube O1, its debut product. More than a gadget, Cube O1 is a palm-sized, cyberpunk-inspired culinary companion with a built-in brain. Think of it as a thermal vision expert and a tiny neural network, sitting discreetly by your stove. It quietly observes the heat, analyzing the cooking process in real-time, and delivers perfectly timed guidance. No voice assistant, no disruptive chatter, just clean, intuitive beeps and gentle light cues designed to keep you effortlessly in the flow of creation.

Philosophy: Redefining the Human-AI Partnership in the Kitchen

At Cue Chef Innovation, we believe technology should augment human capability, not replace it. Cube O1 embodies a “Jarvis-like” collaborative model for the kitchen, where AI acts as a supportive extension of the cook’s own senses and intuition.

• Human-Centric AI: We move beyond automation to assistance. Cube O1 is designed to help home cooks explore further, master intricate techniques, and replicate their best results with confidence. It turns personal culinary flair into a tangible, repeatable personal cookbook.
• The “Event Stream”: Cooking as Data Science: We introduce a novel “cooking event stream” paradigm. Cube O1 transforms real-world variables—precise pan temperature, action timing, duration—into a structured sequence of events and actions. This allows cooking to be recorded, analyzed, and optimized like never before. It’s about cooking the data to perfect the dish.
• Inclusive by Design: We are committed to “frictionless” assistive technology. Cube O1 is designed for universal accessibility, ensuring that the pleasures and rewards of cooking are available to everyone, regardless of their technical proficiency or experience level. In the world of food, exploration should be an equal opportunity.
• The Soul of Cooking: Cooking is more than sustenance. It’s a language of love, a therapeutic ritual, and a passport to global cultures from your own kitchen. Cube O1 helps codify that feeling, transforming ephemeral moments into repeatable, shareable, and passable experiences living cookbook powered by your personal journey.

The Cube O1 Experience: Precision, Privacy, and Community

1. Cue: Capturing Your Culinary DNA
When you cook a dish with Cube O1, it captures the recipe’s essential fingerprint—the exact time, temperature, and key transition points. This “Cooking DNA” liberates your recipe from being tied to one specific pot or stove. Recreate your perfect steak or sauce in any kitchen with identical timing and heat profiles and achieve the same excellent results.

2. Chef: Kitchen-First Design
Every detail of Cube O1 is crafted for the kitchen environment:

• Magnetic Mounting: Securely attaches to range hoods, refrigerators, or any metal surface for optimal viewing.
• Splash-Resistant Build: Withstands the inevitable splatters and steam of an active kitchen.
• Ambient Light UI: Communicates through an intuitive system of colored lights and pulses, delivering information briefly without interrupting your focus.

3. AI: On-Device Intelligence for Real-Time Responsiveness

• Self-Contained & Offline-Capable: The core AI runs directly on the device, ensuring instantaneous response without requiring a constant internet connection.
• Privacy-First Data Handling: All processing prioritizes user privacy. Personal cooking data is anonymized and dissociated from identity.
• “Split-Brain” Architecture: The “little brain” (on-device) processes real-time thermal and sequential data for immediate cues. The optional “big brain” (cloud) handles abstracted, anonymized data for long-term pattern learning and community features, offering the best of both worlds.

4. Club: A Global Kitchen Community
Your personal expertise and unique taste become a shareable cookbook. Cue Chef Club is a vibrant platform where you can publish your “heat-mapped” recipes, discover and try creations from cooks worldwide, and elevate your skills beyond the confines of your own kitchen. Great taste should flow freely, no longer trapped in the imprecise “spellbooks” of traditional recipes.

Core Features at a Glance:

• Recorder: Captures your entire cooking flow—sear duration, flip moment, true pan temperature—turning your best dish into a reproducible pattern, not a happy accident.
• Editor: Transforms the recorded pattern into a clear, shareable recipe. Add ingredients, seasoning notes, and step-by-step descriptions.
• Replayer: Guides you through recreating any dish with step-by-step cues. Gentle beeps and lights signal when to act, eliminating constant video checks or guesswork about heat levels. Just cook, glance, and proceed.
• Club: Connect, share, and explore within a community dedicated to precision cooking.

The Team Behind the Vision

Cue Chef Innovation is powered by a passionate cross-disciplinary team of engineers, designers, and food enthusiasts. Our expertise spans artificial intelligence, embedded systems, thermal imaging, and user-centric design. We thrive where cutting-edge innovation meets the authentic, human experience of cooking. We see cooking as simultaneously an art, a science, and a powerful form of cultural exchange. With Cube O1, our mission is to bridge kitchens and cultures worldwide by making personal technique structured, shareable, and accessible to all.

Availability

The Cube O1 will launch soon via a Kickstarter campaign. For more information, updates, and to be notified at launch, please visit www.cuechef.com.

About Cue Chef
Cue Chef Innovation is dedicated to creating intelligent kitchen assistants that empower people to cook with greater confidence, creativity, and consistency. By harmonizing advanced sensor technology with intuitive design, we aim to make professional-level cooking precision accessible in every home.

Email: contact@cuechef.com
Website: www.cuechef.com

LONDON, Dec. 5, 2025 /PRNewswire/ — The world’s most iconic startup event 4YFN26 will return to the halls of Fira de Barcelona’s iconic Gran Via during GSMA’s MWC26 Barcelona next year for a groundbreaking showcase of 2026’s most exciting startups. Selected from hundreds of submissions, 2026’s Top 20 startups showcase the brightest ideas and leading minds from across five key industry categories.

Culminating with the 4YFN26 Awards, the Top 20 will compete to be crowned overall winner. The 4YFN Top 20 will take part in the 4YFN Awards semifinals on the first day of 4YFN Barcelona. This on-stage pitch competition will take place in front of a panel of leading investors and industry experts. The panel will evaluate them on criteria including innovation, scalability, and impact – before choosing five finalists on the same day.

The five finalists will advance to the 4YFN Awards Final, where they will compete again on the Banco Sabadell stage on 4 March, this time for the coveted prize of 4YFN Awards winner. The winner will receive a €20,000 cash prize, courtesy of the GSMA Foundry.

The 4YFN26 Awards Top 20 are:

Climate Tech

• Greenlyte Carbon Technologies GmbH (Germany) – capturing CO₂ from the air and converting it into green hydrogen and synthetic fuel feedstocks.
• Sensegrass (UK) – improving farm productivity with AI analytics, IoT, and soil intelligence that optimise input use and crop health.
• Skyfora (Finland) – enhancing weather forecasting with AI-powered weather intelligence solutions to predict and adapt to extreme weather. 
• URAPHEX (Spain) – regenerating industrial water through chemical free, sustainable treating processes that reduce pollution.

Digital Horizons

• AIM Intelligence (Korea) – AI security middleware detecting, targeting and eliminating risks in AI enterprise systems.
• DeepKeep (Israel) – protecting enterprise AI models and data pipelines with security tools designed for emerging threat landscapes.
• Enhans (Korea) – building AI driven commerce infrastructure and operating systems for large scale digital transactions.
• NeuralTrust (Spain) – helping companies deploy and scale generative AI safely by protecting applications and agents from misuse or data leaks.

Fintech

• Dost (Spain) – automating finance operations for growing businesses with AI-driven workflows.
• DRUO (USA) – enabling people and businesses to pay directly from bank accounts, removing the need for cards.
• Kistpay Private Limited (Pakistan) – increasing access to smartphones through instalment-based financing for users across emerging markets.
• Spendbase (Ukraine) – reducing SaaS, cloud, and card spend for companies through unified cost management tools.

Health Tech

• AI Diagnostics (South Africa) – delivering AI-powered diagnostic tools that support screening and early detection of TB in low-resource healthcare environments.
• Biorce (Spain) – automating clinical trial operations with AI agents that streamline planning and execution for research teams.
• Medwise AI (UK) – providing clinicians with fast, evidence-based answers that improve care decisions at the point of delivery.
• Sycai Medical (Spain) – using AI imaging to identify and track pre-cancerous pancreatic lesions for earlier clinical intervention.

Mobile Frontiers

• ConnectHear (Pakistan) – creating accessible communication for deaf users through real-time sign language interpretation and AI-assisted alerts.
• Kreios Space SL (Spain) – developing systems to extend satellite lifetimes in very low Earth orbit.
• OptAI (Korea) – optimising on-device AI performance with tools that boost speed, privacy, and efficiency.
• ZIM Connections (UK) – simplifying global connectivity by enabling travellers to activate region specific eSIM plans through a single platform.

Register for 4YFN26 today

Each year, 4YFN brings together investors, founders, and industry leaders to explore the ambitious ideas and cutting-edge technologies shaping the next wave of innovation. Its new theme for 2026, Infinite AI, captures the bold energy of founders pushing the boundaries of artificial intelligence while reflecting 4YFN’s role as a dynamic hub where ideas collide, deals form, and breakout companies step into the global spotlight. In 2026, 4YFN will showcase hundreds of startups across five stages in Halls 8.0 and 8.1, offering packed demo floors, live pitch sessions, and a programme designed to connect founders with investors, corporates, and global media. Book your place at 4YFN26 here.

Click here to read the full press release.

– France becomes Seegene’s ninth overseas sales subsidiary and third in Europe, following Italy and Germany

– The country ranks as Europe’s second-largest molecular diagnostics market, driven by demand in sexually transmitted infections and gastrointestinal testing, and respiratory virus detection.

– The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

SEOUL, South Korea, Dec. 5, 2025 /PRNewswire/ — Seegene, Inc., a global leader in molecular diagnostics (MDx), announced today the establishment of a new subsidiary in France to reinforce its European presence and support global sales expansion.

The new subsidiary will strengthen local engagement with customers and partners through enhanced technical support, market development and collaboration with healthcare stakeholders.

According to global market research firm Grand View Research, Inc., France’s MDx market is estimated to reach approximately EUR 600 million, accounting for around 15 percent of Europe’s total. It is the second-largest market in the region after Germany, which holds a 19 percent share. Demand in France is particularly high for diagnostic tests targeting sexually transmitted infections (STIs), gastrointestinal (GI) tract infections, and respiratory infections. Through its subsidiary, Seegene aims to expand sales of these product lines while introducing a broader portfolio including cervical cancer and other multiplex diagnostic categories.

“On the French market, which is divided between the private and public sectors, the ability to quickly deliver innovative products and meet laboratories’ efficiency needs is a key factor for competitiveness,” said Daniel Shin, Executive Vice President and Chief Global Sales and Marketing Officer at Seegene. “The subsidiary will enable Seegene to gain a better understanding the French healthcare landscape, strengthening local customer service, and accelerate the growth of the company’s in vitro diagnostics business with dedicated local expertise.”

The subsidiary also provides a strategic foothold for the European rollout of Seegene’s solutions that are in development, CURECA™, a fully automated, unmanned PCR system, and STAgora™, a real-time diagnostic data analytics and predictive insights platform.

The addition of France brings Seegene’s overseas sales subsidiaries to nine, complementing its global distribution network of 90 distributors across 94 countries.

As of the first half of 2025, overseas sales accounted for approximately 93 percent of Seegene’s total revenue, with Europe representing 63 percent. The region remains a key growth driver for the company’s global expansion roadmap.

Disclaimer

CURECA™ and STAgora™ are under development and not available for diagnostic use.

About Seegene

Seegene has more than 25 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene’s syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information.

Visit: Seegene.com and follow linkedin.com/company/seegene-inc

• Demonstrated brain imaging analysis solutions, including ‘Neurophet AQUA AD,’ which enables monitoring of adverse effects associated with Alzheimer’s disease treatments
• Highlighted clinical cases that improved the safety of anti-amyloid therapy administration during an AI Theater session

SEOUL, South Korea, Dec. 5, 2025 /PRNewswire/ — Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 5th that it participated in the 111th Radiological Society of North America (RSNA 2025) and presented real-world clinical use cases of its key brain imaging analysis AI solutions.

At the conference, Neurophet showcased its software ‘Neurophet AQUA AD,’ which supports monitoring of Alzheimer’s disease treatment prescription, therapeutic response, and potential adverse effects. Neurophet AQUA AD provides precise brain imaging analysis throughout the administration of anti-amyloid antibody therapies by quantitatively analyzing magnetic resonance imaging (MRI) and positron emission tomography (PET) scans.

In addition, real-world clinical use cases of Neurophet AQUA AD were demonstrated during the AI Theater session held in the exhibition hall. In this session, Professor Chong Hyun Suh from the Department of Radiology at Asan Medical Center, University of Ulsan College of Medicine, delivered a lecture titled “AI-Powered Monitoring of Amyloid-Related Imaging Abnormalities in Anti-Amyloid Therapy: Neurophet AQUA AD.”

Professor Suh introduced AI-based ARIA detection and quantification technologies that address the limitations of conventional manual approaches. He also elaborated how AI enhances the safety and clinical effectiveness of anti-amyloid therapies by presenting various real-world clinical cases in which patients receiving Alzheimer’s disease treatments developed ARIA.

Through booth exhibition, Neurophet also presented Neurophet AQUA AD alongside its other solutions, including Neurophet AQUA, a brain neurodegeneration imaging analysis software, and Neurophet SCALE PET, a PET imaging quantification software.

The company highlighted the technological excellence of Neurophet AQUA MS, which was first unveiled at last year’s RSNA. Neurophet AQUA MS is a software module integrated into Neurophet AQUA that analyzes brain images of patients with multiple sclerosis, a refractory central nervous system disorder. The solution received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October of last year.

Jake Junkil Been, Co-CEO of Neurophet, stated, “Neurophet AQUA AD has been gaining significant attention from major domestic and global companies in the field of imaging analysis for Alzheimer’s disease treatment planning. Through partnerships with global medical device companies at RSNA 2025, we plan to accelerate the expansion of our key products in the North American market.”

Meanwhile, RSNA 2025 is the world’s largest radiology conference, attended by radiologists and global medical device industry professionals, and is held annually in Chicago, USA. This year’s conference took place from November 30 to December 4 (local time).

About Neurophet

Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.

Major products include brain MRI analysis software “Neurophet AQUA”, PET Image Quantitative Analysis Software “Neurophet SCALE PET”, Brain imaging treatment planning software for electric and magnetic brain stimulation “Neurophet tES/TMS LAB”, Alzheimer’s Disease treatment prescription and monitoring software “Neurophet AQUA AD” for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software “Neurophet AQUA MS”.

Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain’s health and pioneer solutions for brain diseases with AI technology.